Clinical trials
Phase 2 Lung Neoplasms trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 3 |
| Pfizer | 3 |
| Arcus Biosciences, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Boehringer Ingelheim | 1 |
| Cancer Therapeutics Research Group | 1 |
| Eisai Inc. | 1 |
| Gilead Sciences | 1 |
| Sanofi | 1 |
| The University of Hong Kong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 16 |
| Carcinoma, Non-Small-Cell Lung | 12 |
| Adenocarcinoma of Lung | 3 |
| Adenocarcinoma, Bronchiolo-Alveolar | 1 |
| Carcinoma | 1 |
| Lung Diseases | 1 |
| Neoplasm Metastasis | 1 |
| Small Cell Lung Carcinoma | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.